Filing Flows

Filing Flows › Health Care › Electromed (ELMD)

Electromed (ELMD) earnings and revenue breakdown

Latest: Q4 FY26 · 10-K filed Aug 25, 2026 · Electromed (ELMD) Q4 FY26 earnings results →

Q4 FY26 Revenue up 12% year over year to $19.4M · 18¢ of every $1 of revenue kept as net profit · operating margin 19.7%

Electromed made $19.4M in Q4 FY26 (+12% Y/Y). Operating margin 19.7%, net earnings $3.4M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-K filed Aug 25, 2026.

Revenue$19.4M
Year over year+12%
Operating margin19.7%
Net earnings$3.4M
Operating cash flow$3.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $19.4M in Q4 FY26, up 12% year over year and up 5% from the previous quarter.

Gross margin was 78.7%, up 0.4 points from Q4 FY25. Operating profit was $3.8M, a 19.7% margin (up 2.2 points year over year). Of the extra revenue versus Q4 FY25, 39% reached operating profit, above the 17% margin then. Operating expenses grew 8% against revenue growth of 12%. Net earnings were $3.4M, up 54% year over year. The effective tax rate was 14.1%.

Operating cash flow was $3.0M (down 22% year over year), 88% of net earnings. Non-cash charges added back $122K of depreciation and amortization and $762K of share-based compensation. Working capital and other items used $1.3M. Capital expenditures of $219K left free cash flow of $2.8M.

Quarterly history

Electromed revenue by quarterElectromed revenue by quarter$16.3MQ2 FY25$15.7MQ3 FY25$17.4MQ4 FY25$16.9MQ1 FY26$18.9MQ2 FY26$18.6MQ3 FY26$19.4MQ4 FY26
Electromed net earnings by quarterElectromed net earnings by quarter$2.0MQ2 FY25$1.9MQ3 FY25$2.2MQ4 FY25$2.1MQ1 FY26$2.8MQ2 FY26$3.0MQ3 FY26$3.4MQ4 FY26
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q4 FY2610-KAug 25, 2026$19.4M+12%19.7%$3.4M$3.0M
Q3 FY2610-QMay 12, 2026$18.6M+18%20.3%$3.0M$3.5M
Q2 FY2610-QFeb 10, 2026$18.9M+16%19.2%$2.8M$3.0M
Q1 FY2610-QNov 12, 2025$16.9M+15%15.8%$2.1M$169K
Q4 FY2510-KAug 26, 2025$17.4M+17%17.5%$2.2M$3.9M
Q3 FY2510-QMay 13, 2025$15.7M+13%13.6%$1.9M$2.1M
Q2 FY2510-QFeb 11, 2025$16.3M+19%15.6%$2.0M$3.2M

Charts

Electromed: revenue growth, year over year and quarter over quarterElectromed: revenue growth, year over year and quarter over quarterY/YQ/Q+19%Q2 FY25+13%-4%Q3 FY25+17%+11%Q4 FY25+15%-3%Q1 FY26+16%+12%Q2 FY26+18%-2%Q3 FY26+12%+5%Q4 FY26
Latest (Q4 FY26): Y/Y +12%, Q/Q +5%.
Electromed: where the cash came from (+) and went (−), FY26Electromed: where the cash came from (+) and went (−), FY26Operating cash flow$9.7MCash drawn (+) / kept (−)−$5.2MBuybacks−$3.9MCapital spending−$1.3MShares issued$965KTaxes on employees’ shares−$249KOther investing−$48K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Electromed: profit against cash, quarter by quarterElectromed: profit against cash, quarter by quarterNet incomeOperating cash flow$1.5M$2.3MQ1 FY25$2.0M$3.2MQ2 FY25$1.9M$2.1MQ3 FY25$2.2M$3.9MQ4 FY25$2.1M$169KQ1 FY26$2.8M$3.0MQ2 FY26$3.0M$3.5MQ3 FY26$3.4M$3.0MQ4 FY26
Latest (Q4 FY26): Net income $3.4M, Operating cash flow $3.0M.
Electromed: diluted shares by fiscal yearElectromed: diluted shares by fiscal year9MFY219MFY229MFY239MFY249MFY259MFY26
-2.5% since FY21: buybacks shrank the count.
Electromed in its industry: growth against margin (25 companies, SIC 3845)Electromed in its industry: growth against margin (25 companies, SIC 3845)revenue growth, year over year →↑ operating marginmedian +14%median -8%MDTITGRLIVNCNMDTMDXAXGNOMCBLLBLFSIRIXVASOFOCLECORPOCISTXSQTIHYPRESMCCVNUWENRXSADMTPOSCNXLELMD (+12%, 20%)
Electromedical & Electrotherapeutic Apparatus; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Electromed

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com .

In its own words, from its 8-K, filed Aug 25, 2026.

Electromed against its Electromedical & Electrotherapeutic Apparatus peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +12% against the peers' median +14%. Operating margin: 19.7% against the peers' median 7.2%.

CompanyQuarterRevenueY/YOp. margin
ELMD ElectromedQ4 FY26$19.4M+12%19.7%
MDT MedtronicQ1 FY27$9.8B+14%18.1%
ITGR Integer HoldingsQ3 2026$450M-4%6.3%
LIVN LivaNovaQ3 2026$393M+10%7.2%
CNMD ConmedQ3 2026$336M-0.7%11.1%
TMDX TransMedics GroupQ3 2026$203M+41%13.9%
AXGN AxogenQ3 2026$75.8M+26%1.3%
OM Outset MedicalQ3 2026$33.6M+14%-36.5%
CBLL CeribellQ3 2026$29.3M+30%-70.0%

Source: Electromed 10-K on SEC EDGAR · CIK 1488917 · Electromedical & Electrotherapeutic Apparatus

13F: who owns ELMD and who is buying

Largest holders of ELMD (13F)Largest holders of ELMD (13F)J.E. Simmons & Co., P.C.$20.5MBlackRock$19.7MVanguard Group$13.0MVanguard Capital Management LLC$12.0MAcadian Asset Management LLC$9.4MPunch & Associates Investment Man…$9.2MGeode Capital Management, LLC$9.2MDimensional Fund Advisors LP$7.6MTwo Sigma Investments, LP$7.1MGamco Investors, Inc. et Al$6.0M
Funds' net buying of ELMD by quarter (13F)Funds' net buying of ELMD by quarter (13F)$893K2024-09$937K2024-12$11.5M2025-03$2.1M2025-06$826K2025-09$4.3M2025-12−$251K2026-03$4.8M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on ELMD

History

Every quarter: Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results

Compare ELMD with

中文版：Electromed（ELMD）财报

Español · Français